Crinetics Pharmaceuticals, Inc.
corporate_fare Company Profile
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 29 items for CRNX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-01, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 16 rated 8 or above. Recent SEC coverage for CRNX spans 8-K, 10-Q, DEFM14A, PREM14A.
Recent high-impact activity:
- Vertex Completes $10B Acquisition of Crinetics; CRNX to Be Delisted
- Crinetics Shareholders Approve $10B Vertex Merger; Golden Parachute Vote Fails
- Crinetics Discloses Shareholder Lawsuits and Supplemental Proxy Details Ahead of Vertex Merger Vote
- Crinetics Clears Antitrust Hurdles; Shareholder Vote Set for Aug 28
- Crinetics Q2 Revenue Soars on PALSONIFY Launch, But Guidance Pulled
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$7.7M
Net Income
-$465.32M
Diluted EPS
-$4.95
Op. Cash Flow
-$377.92M
Free Cash Flow
-$383.68M
Gross Profit
$6.62M
Operating Income
-$516.77M
Cash & Equivalents
$101.54M
Debt / Equity
0.00×
Net Margin
-60.46×
Shares Outstanding
95.58M sh
Source: 10-K · filed 2026-02-26 · accession 0001658247-26-000012
feed CRNX - Latest Insights
CRNX
Sep 01, 2026, 9:26 AM EDT
CRNX
Aug 28, 2026, 5:00 PM EDT
CRNX
Aug 19, 2026, 4:04 PM EDT
CRNX
Aug 14, 2026, 8:30 AM EDT
CRNX
Aug 03, 2026, 4:22 PM EDT
CRNX
Aug 03, 2026, 4:13 PM EDT
CRNX
Aug 03, 2026, 4:09 PM EDT
CRNX
Jul 31, 2026, 4:17 PM EDT
CRNX
Jul 21, 2026, 4:30 PM EDT
CRNX
Jul 10, 2026, 4:01 PM EDT
CRNX
Jul 07, 2026, 7:33 AM EDT
CRNX
Jul 06, 2026, 5:24 PM EDT
CRNX
Jul 06, 2026, 5:18 PM EDT
CRNX
Jul 06, 2026, 5:17 PM EDT
CRNX
Jul 06, 2026, 4:04 PM EDT
CRNX
Jun 14, 2026, 2:45 PM EDT
CRNX
Jun 03, 2026, 3:15 AM EDT
CRNX
May 07, 2026, 4:21 PM EDT
CRNX
May 07, 2026, 4:16 PM EDT
CRNX
Apr 27, 2026, 5:13 PM EDT